Skip to main content
. 2021 Oct 19;11:109. doi: 10.1186/s13550-021-00845-z

Table 8.

Prevalence of discordant presumable unspecific lesions

Type of presumable unspecific lesion [18F]-F-PSMA-1007 [n] [68Ga]-Ga-PSMA-11 [n] p
Lymph node Total (Σ; uni/oligo/multi) 24 (52.2%); 3/9/12 13 (28.3%); 0/10/3 < 0.001
Total patients with more lesion 18 (39.1%) 1 (2.2%)
Axillary 18 (39.1%) 1 (2.2%)
Mediastinal/hilar 6 (13.0%)
Inguinal 5 (10.9%)
Osseous Total patients (Σ; uni/oligo/multi) 33 (71.7%); (4/7/22) 11 (23.9%); (5/6/0) < 0.001
Total patients with more lesion 28 (60.9%)
Total lesions/more lesions ribs 28/27 (58.7%) 6/0 < 0.001
Total lesions/more lesions spine 15/11 (23.9%) 4/0 < 0.001
Total lesions/more lesions pelvis 6/5 (10.9%) 1/0 0.025
Total lesions/more lesions scapula 6/5 (10.9%) 1/0 0.025
Total lesions/more lesions sternum 5/5 (10.9%) 0 0.025
Total lesions/more lesions femur 2/2 (4.3%) 0 0.157
Ganglia Total patients with any ganglia uptake 33 (71.7%) 20 (43.5%) < 0.001
Total lesions/more lesions cervical 30/13 (28.3%) 17/0 < 0.001
Total lesions/more lesions coeliac 17/9 (19.6%) 8/0 < 0.001
Total lesions/more lesions sacral 8/5 (10.9%) 3/0 0.025
Thyroid Total patients 26 (56.5%) 4 (8.7%) < 0.001
Total patients with higher uptake 22
Esophagus Total patients 11 (23.9%) 24 (52.2%) < 0.001
Total patients with higher 13
Ileocoecal Total patients diffuse uptake 3 (6.5%) 1 (2.1%) 0.157
Pancreas Total patients diffuse pancreatic uptake 2 (4.3%) 1 (2.1%) 0.317